Competing risks for patients with localized prostate cancer.
Seidenfeld
Jerome
J
Samson
David J
DJ
Albertsen
Peter C
PC
D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000401:mortality*; D017024:Chemotherapy, Adjuvant; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D012107:Research Design / Q000592:standards; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D015983:Selection Bias
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal